Literature DB >> 23148173

Endocrine and metabolic emergencies: hypoglycaemia.

Elora Mukherjee1, Richard Carroll, Glenn Matfin.   

Abstract

Hypoglycaemia is rare in healthy individuals owing to the numerous elegant hormonal and neuronal mechanisms that maintain glucose homeostasis. Glucose is an obligate metabolic fuel for cerebral tissue and therefore hypoglycaemia, if uncorrected, can have disastrous consequences including death. Clinical hypoglycaemia is defined as a plasma (or serum) glucose concentration low enough to cause symptoms and/or signs, including impairment of brain function. However, no single plasma (or serum) glucose concentration categorically defines hypoglycaemia. Hypoglycaemia is probably the most common endocrine and metabolic emergency in clinical practice. The overwhelming majority of occurrences of hypoglycaemia occur in patients with diabetes, either as a result of treatment-induced hypoglycaemia and/or abnormalities that affect the normal counterregulatory response to hypoglycaemia. The differential for nondiabetes-associated hypoglycaemia is broad and includes insulinoma, drugs, hormone deficiencies, and critical illness. The acute management of hypoglycaemia is discussed along with a review of the pathophysiology and aetiology of this commonly encountered clinical problem.

Entities:  

Keywords:  drug-induced hypoglycaemia; hyperinsulinaemia; hypoglycaemia; insulinoma

Year:  2011        PMID: 23148173      PMCID: PMC3474629          DOI: 10.1177/2042018811401644

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  28 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 2.  Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system.

Authors:  K Oberg; L Kvols; M Caplin; G Delle Fave; W de Herder; G Rindi; P Ruszniewski; E A Woltering; B Wiedenmann
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

3.  Well-differentiated pancreatic tumor/carcinoma: insulinoma.

Authors:  Wouter W de Herder; Bruno Niederle; Jean-Yves Scoazec; Stanislas Pauwels; Gunter Kloppel; Massimo Falconi; Dik J Kwekkeboom; Kjel Oberg; Barbro Eriksson; Bertram Wiedenmann; Guido Rindi; Dermot O'Toole; Diego Ferone
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

4.  Adrenal insufficiency.

Authors:  Wiebke Arlt
Journal:  Clin Med (Lond)       Date:  2008-04       Impact factor: 2.659

5.  The diagnosis of postprandial hypoglycemia.

Authors:  A Lev-Ran; R W Anderson
Journal:  Diabetes       Date:  1981-12       Impact factor: 9.461

6.  Insulin autoimmunity and hypoglycemia in seven white patients.

Authors:  Ananda Basu; F John Service; Liping Yu; Don Heser; Laura M Ferries; George Eisenbarth
Journal:  Endocr Pract       Date:  2005 Mar-Apr       Impact factor: 3.443

Review 7.  Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

Authors: 
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

8.  Everolimus for advanced pancreatic neuroendocrine tumors.

Authors:  James C Yao; Manisha H Shah; Tetsuhide Ito; Catherine Lombard Bohas; Edward M Wolin; Eric Van Cutsem; Timothy J Hobday; Takuji Okusaka; Jaume Capdevila; Elisabeth G E de Vries; Paola Tomassetti; Marianne E Pavel; Sakina Hoosen; Tomas Haas; Jeremie Lincy; David Lebwohl; Kjell Öberg
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

9.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

10.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

View more
  4 in total

1.  Hypoglycaemia in a 94-year-old man without diabetes.

Authors:  Dustin James Mullens; Jay H Shubrook
Journal:  BMJ Case Rep       Date:  2014-05-20

2.  Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Ghulam M Ashraf; Nigel H Greig; Taqi A Khan; Iftekhar Hassan; Shams Tabrez; Shazi Shakil; Ishfaq A Sheikh; Syed K Zaidi; Mohammad Akram; Nasimudeen R Jabir; Chelaprom K Firoz; Aabgeena Naeem; Ibrahim M Alhazza; Ghazi A Damanhouri; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 3.  Endocrinological disorders affecting neurosurgical patients: An intensivists perspective.

Authors:  Sukhminder Jit Singh Bajwa; Rudrashish Haldar
Journal:  Indian J Endocrinol Metab       Date:  2014-11

4.  Serum glucose, urea nitrogen, cholesterol, and total proteins in crossbred repeat breeder and normally cyclic cows.

Authors:  Rashed Khan Barson; Shasthi Padder; Abu Sadath Md Sayam; Mohammad Moshiur Rahman; Mohammad Musharraf Uddin Bhuiyan; Jayonta Bhattacharjee
Journal:  J Adv Vet Anim Res       Date:  2019-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.